Open AccessCOVID-19 and obesity: what is known about the features of pathogenesis and treatment?
Author(s) -
С. Г. Канорский
Publication year - 2021
Publication title -
ûžno-rossijskij žurnal terapevtičeskoj praktiki
Language(s) - English
Resource type - Journals
ISSN - 2712-8156
DOI - 10.21886/2712-8156-2021-2-1-17-24
Subject(s) - obesity , pandemic , medicine , covid-19 , overweight , disease , pathogenesis , intensive care medicine , medline , immunology , pathology , infectious disease (medical specialty) , biology , outbreak , biochemistry
The increasing prevalence of overweight and obesity is a public health problem worldwide. During the COVID-19 pandemic, obesity is associated with a higher risk of severe disease and adverse clinical outcome of SARS-CoV-2 infection. It may be associated with chronic systemic inflammation, impaired immune response and metabolic disturbances in obese patients. In order to establish possible pathogenetic links between obesity and COVID-19, an analysis of experimental, clinical studies, their meta-analyzes, literature reviews from the PubMed/MedLine database was carried out using the keywords «COVID-19» and «obesity». This review discusses the potential pathogenesis and treatment features of obese patients with COVID-19.